{
"id":"mk19_a_on_t08",
"number":8,
"bookId":"on",
"title":{
"__html":"International Federation of Gynecology and Obstetrics Cervical Cancer Staging and Treatment"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"37f8b4",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 8. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_on_t08"
}
]
},
"International Federation of Gynecology and Obstetrics Cervical Cancer Staging and Treatment"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64c6da",
"class":"col hd l",
"children":[
"Stage"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c4ac0",
"class":"col hd l",
"children":[
"Treatment"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c98af",
"class":"cell txt l",
"children":[
"I: Carcinoma is strictly confined to the cervix"
]
},
" ",
{
"type":"p",
"hlId":"c21a7b",
"class":"cell txt li",
"children":[
"IA: Microscopic disease only, up to 5 mm in depth"
]
},
" ",
{
"type":"p",
"hlId":"6e98e8",
"class":"cell txt li",
"children":[
"IB: Clinically visible disease, or microscopic disease >5 mm"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8875d",
"class":"cell txt l",
"children":[
"IA and IB: Modified radical (for lesions <2 cm) or radical hysterectomy with pelvic lymph node dissection is preferred; if poor functional status, irradiation can be used instead."
]
},
" ",
{
"type":"p",
"hlId":"bf2417",
"class":"cell txt l",
"children":[
"If treated with surgery, adjuvant irradiation or chemoradiation is added if indicated based on final pathology."
]
},
" ",
{
"type":"p",
"hlId":"e3f041",
"class":"cell txt l",
"children":[
"Fertility preservation surgery is an option for cancers ≤2 cm with no lymph node metastases."
]
},
" ",
{
"type":"p",
"hlId":"6a80d6",
"class":"cell txt l",
"children":[
"IA: Simple hysterectomy, cone biopsy (conization), or removal of cervix (trachelectomy) are options."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e763b",
"class":"cell txt l",
"children":[
"IIA and IIB: Cervical carcinoma invades beyond the uterus, but not to the pelvic wall or lower third of the vagina. IIB has parametrial invasion."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6fe357",
"class":"cell txt l",
"children":[
"IIA: Same as for stage I"
]
},
" ",
{
"type":"p",
"hlId":"f86690",
"class":"cell txt l",
"children":[
"IIB: Same as for stage III"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"08aa19",
"class":"cell txt l",
"children":[
"III: The tumor extends to the pelvic wall, involves the lower third of the vagina, causes hydronephrosis or nonfunctioning kidney, and/or involves the pelvic or para-aortic lymph nodes."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01cf56",
"class":"cell txt l",
"children":[
"III: Irradiation with concurrent platinum-based chemotherapy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c36338",
"class":"cell txt l",
"children":[
"IV: The carcinoma extends beyond the true pelvis or involves the mucosa of the bladder or rectum."
]
},
" ",
{
"type":"p",
"hlId":"2aa886",
"class":"cell txt li",
"children":[
"IVA: Spread to adjacent organs"
]
},
" ",
{
"type":"p",
"hlId":"cfe325",
"class":"cell txt li",
"children":[
"IVB: Distant metastases"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64a0b2",
"class":"cell txt l",
"children":[
"IVA: Same as for stage III"
]
},
" ",
{
"type":"p",
"hlId":"0a705b",
"class":"cell txt l",
"children":[
"IVB: Palliative cisplatin-based chemotherapy, with irradiation for local symptoms, such as bleeding or pain. Pembrolizumab is approved for second-line treatment in patients with programmed death ligand 1−positive tumors."
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}